Key facts
- This page summarizes Enrico Picozza's Form 4 filing for DermTech, Inc..
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 May 2021, 20:18.
Enrico Picozza - 26 May 2021 Form 4 Insider Report for DermTech, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 26 May 2021
- Net transaction value
- -$813,577
- SEC form
- 4
- Accepted by SEC
- 28 May 2021, 20:18:27 UTC
- Prior SEC filing
- 25 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason S. Miller, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Enrico Picozza filed Form 4 for DermTech, Inc. on 28 May 2021.
Change
- Previous filing in this sequence was filed on 25 May 2021.
- Current net transaction value: -$813,577.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DMTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,497
- Change %
- +32%
- Price
- $0.000000
- Shares after
- 18,497
- Date
- 26 May 2021
- Ownership
- Direct
- Footnotes
- F1
DMTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,661
- Change %
- +25%
- Price
- $0.000000
- Shares after
- 23,158
- Date
- 26 May 2021
- Ownership
- Direct
- Footnotes
- F2
DMTK
transaction
Common Stock
Sale
- Transaction value
- $813,577
- Shares
- -20,297
- Change %
- -3.9%
- Price
- $40.08*
- Shares after
- 500,000
- Date
- 26 May 2021
- Ownership
- By HLM Venture Partners IV, L.P.
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on May 26, 2022.
Footnote F2
The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest, and the shares underlying the restricted stock units shall be released to the reporting person, on January 1, 2023, subject to the reporting person's continued service.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $40.00 to $40.32, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
Footnote F4
The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.